1. Adams S S, Bresloff P, Mason CG. Pharmacological differences between the optical isomeres of ibuprofen: evidence for metabolic inversion of (-)-isomer. J Pharm Pharmacol 1976;28:256–7.
2. Evans AM. Pharmacodynamics and pharmacokinetics of the profens: enantioselectivity, clinical implications, and special reference to S(+)-ibuprofen. J Clin Pharmacol 1996;36:7–15.
3. Klein G, Neff H, Kullich W, Phleps W, Kollenz CJ. S(+) versus racemic ibuprofen. Lancet 1992;339:681.
4. Rahlfs VW. Reevaluation of some double-blind randomized studies of dexibuprofen (Seractil): a state-of-the-art overview. J Clin Pharmacol 1996;36:S33–40.
5. Comparison of the bioavailability after a single-dose oral administration of tablets containing 400 mg S(+)ibuprofen under fasting and non-fasting conditions. Internal report Gebro Pharma 1/24.3, 1999.